Latest News From KnowTheRisk.com

A Turnaround for Testing? 04/27/2012

Medical testing has been used by the insurance industry for more than half a century to screen applicants for medical problems and to further evaluate those with known medical illness. The a priori assumption of course is that all such testing is accurate, cost effective, and of benefit to all parties concerned.

In recent developments, medical professionals have been taking a closer look at certain types of testing used both to screen for and manage various types of medical problems. This closer look was prompted by studies over the past several years that indicated that testing in some circumstances not only failed to achieve its goal but could in fact be misleading and in some instances downright harmful.

In response to these developments, professional medical societies are carefully reviewing risk versus benefit for various types of testing used for screening, diagnosis and management and are making their recommendations available not only to the professional but to the consumer. To date, more than nine professional organizations including The American Academy of Family Physicians, The American College of Physicians, The American College of Cardiology and the American College of Radiology as well as others have published suggested changes or guidelines on a website: www.choosingwisely.org freely available to all.

How will these changes affect the insurance industry or you as an insurance professional?  It is probably too early to tell whether the changes will amount to a corrective shuffle or a paradigm shift. Many of the suggested changes to date are likely to have little or no impact while others may affect either directly or indirectly the way applications are handled, particularly in the area of some of the screening tests commonly used as part of age/amount requirements.

It will take a while for the insurance carriers and their medical directors to mull things over and time to put the new information into perspective. Stay tuned – we will keep you informed.

2 new Rating Guides coming soon! 03/10/2011

Essential Thrombocytosis & Idiopathic Thrombocytopenic Purpura (ITP)
Blood test abnormalities in otherwise healthy insurance applicants challenge the underwriter and the broker who may be presenting a rating or a decline to the client in such cases. Disorders of the platelets, either in the form of too many (thrombocytosis) or too few (thrombocytopenia) are often reported to the underwriter by the physician, in some cases the client not even aware of this condition. Our brand new rating guides on both conditions provide the information you need to KnowtheRisk!   STAY TUNED!!!

Screening for Prostate Cancer with PSA 11/18/2010

Age and amount requirements for the insurance applicant are a fact of life. For the middle-aged male this frequently includes a PSA (prostate specific antigen) determination to screen for prostate cancer.  Early detection of the presence of prostate cancer clearly benefits the asymptomatic applicant and insurance carrier alike, the former by detecting the disease early, the latter by allowing premium adjustments for individuals with excess mortality.

But does it work? Recent investigations would indicate that perhaps the bloom has begun to fade on this particular rose. In a study involving more than 350,000 asymptomatic men, screening with PSA did not decrease either prostate cancer-related mortality nor all-cause mortality bringing into question the benefits for either applicant or insurance carrier.  However, before heaving the baby out with the bath water, it is important to note that other studies of males screened selectively at age 60 have shown that those with PSA levels of less than 2ng/mL have a very low long term risk of developing or dying from prostate cancer while those with levels of 2ng/mL or higher encompassed 90% of those individuals likely to develop and succumb to this disease.

Whether the insurance industry will amend screening practices based on this information is unclear. What is clear however is that PSA screening for the detection of prostate cancer in the asymptomatic male remains a contentious issue for both the medical professional and the insurance carrier  - the evolution continues.

Fit or Fat and Blood Pressure 11/09/2010

One in three North American adults meet the definition for high blood pressure-that is blood pressure over 140/90 and this is the case for at least half the adults over age 55. A  recent study in the American Heart Journal of about 35,000 people suggests weight is  more important than fitness in getting blood pressure under control. After analyzing all the data, it was determined fitness alone couldn't overcome the negative effects of being obese.

For life and particularly CI, DI and LTC underwriting, being overweight and having high blood pressure remain daily concerns as these conditions put a large portion of our clients at greater risk for stroke, heart attack and kidney disease. High blood pressure alone cost North Americans more than $80 billion in 2010 when totalling hospitalization, doctors' consults, drugs and lost time from work.

 

Welcome PPI Solutions guests 10/29/2010

Welcome to KnowtheRisk.  On our site you'll find a wealth of underwriting expertise. See the News item on our recently launched Premium Service.


A Turnaround for Testing? 04/27/2012